Design Therapeutics Ownership | Who Owns Design Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Design Therapeutics Ownership Summary


Design Therapeutics is owned by 116.18% institutional investors, 36.45% insiders. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 12.90% of DSGN shares. iShares Russell 2000 ETF is the top mutual fund, with 1.43% of its assets in Design Therapeutics shares.

DSGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockDesign Therapeutics116.18%36.45%-52.64%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Price t rowe associates inc /md/7.29M12.90%$705.90M
Durable capital partners lp3.46M6.12%$334.67M
Vanguard group3.19M5.65%$309.29M
Conestoga capital advisors3.12M5.52%$301.76M
Jarislowsky, fraser2.89M5.12%$279.97M
Fiera capital2.56M4.53%$248.02M
Primecap management co/ca/2.24M3.96%$216.78M
Mackenzie financial2.13M3.78%$206.81M
Connor, clark & lunn investment management2.05M3.63%$198.72M
T. rowe price investment management1.70M3.00%$164.35M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Zeno equity partners llp266.28K6.86%$25.79M
Conestoga capital advisors3.12M4.52%$301.76M
Herald investment management230.00K3.65%$22.24M
Summit creek advisors258.25K3.43%$25.01M
Aperture investors236.27K3.34%$22.89M
Durable capital partners lp3.46M2.75%$334.67M
Geneva capital management1.46M2.57%$141.16M
Triasima portfolio management253.85K2.25%$24.58M
Pembroke management125.98K2.24%$16.70M
Minichmacgregor wealth management79.95K1.89%$7.74M

Top Buyers

HolderShares% AssetsChange
Congress asset management co /ma1.22M0.85%1.22M
Norges bank1.12M0.02%1.12M
Ubs asset management americas690.48K0.02%690.48K
Blackrock566.21K0.00%213.67K
William blair investment management212.81K0.05%212.81K

Top Sellers

HolderShares% AssetsChange
Arrowstreet capital, limited partnership611.83K0.05%-633.32K
Jarislowsky, fraser2.89M1.70%-438.99K
T. rowe price investment management1.70M0.10%-379.50K
Price t rowe associates inc /md/7.29M0.08%-313.25K
Goldman sachs group391.94K0.01%-213.09K

New Positions

HolderShares% AssetsChangeValue
Congress asset management co /ma1.22M0.85%1.22M$118.30M
Norges bank1.12M0.02%1.12M$108.88M
Ubs asset management americas690.48K0.02%690.48K$66.87M
William blair investment management212.81K0.05%212.81K$20.61M
Charles schwab investment management176.46K0.00%176.46K$17.09M

Sold Out

HolderChange
Financial gravity asset management-11.00
Harbour investments-12.00
Spire wealth management-18.00
Clarivest asset management-22.00
Crewe advisors-50.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20243383.68%65,782,856-1.17%1160.84%160-15.34%12636.96%
Jun 30, 20243236.60%66,550,5312.13%117869551.63%1868.77%92-6.12%
Mar 31, 20243035.57%65,164,649-1.21%-0.00%1714.91%987.69%
Dec 31, 202328712.55%65,959,6981.06%1170.87%16342.98%91-13.33%
Sep 30, 2023255-1.16%65,268,405-1.58%1160.83%114-11.63%10512.90%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF809.27K1.43%-1.82K
Vanguard Total Stock Mkt Idx Inv800.90K1.41%-
Fidelity Select Biotechnology726.40K1.28%20.50K
Vanguard Institutional Extnd Mkt Idx Tr399.50K0.71%-
Fidelity Small Cap Index320.41K0.57%-4.39K
iShares Russell 2000 Value ETF292.40K0.52%-
State St Russell Sm/Mid Cp® Indx NL Cl C272.76K0.48%-6.50K
Fidelity Extended Market Index172.25K0.30%35.33K
Vanguard Russell 2000 ETF142.81K0.25%-884.00
Schwab US Small-Cap ETF™141.34K0.25%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 18, 2024Prasad Deepa-Sell$23.86K
Aug 09, 2024William Arsani-Sell$3.46M
Mar 22, 2024Schmid John P.-Buy$33.13K
Mar 25, 2024Schmid John P.-Buy$66.61K
Mar 25, 2024Berger Heather A.-Buy$4.87K

Insider Transactions Trends


DateBuySell
2024 Q4-1
2024 Q3-1
2024 Q2--
2024 Q13-
2023 Q4--

DSGN Ownership FAQ


Who Owns Design Therapeutics?

Design Therapeutics shareholders are primarily institutional investors at 116.18%, followed by 36.45% insiders and -52.63% retail investors. The average institutional ownership in Design Therapeutics's industry, Biotech Stocks , is 47.04%, which Design Therapeutics exceeds.

Who owns the most shares of Design Therapeutics?

Design Therapeutics’s largest shareholders are Price t rowe associates inc /md/ (7.29M shares, 12.90%), Durable capital partners lp (3.46M shares, 6.12%), and Vanguard group (3.19M shares, 5.65%). Together, they hold 24.68% of Design Therapeutics’s total shares outstanding.

Does Blackrock own Design Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Design Therapeutics.

Who is Design Therapeutics’s biggest shareholder by percentage of total assets invested?

Zeno equity partners llp is Design Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.86% of its assets in 266.28K Design Therapeutics shares, valued at 25.79M$.

Who is the top mutual fund holder of Design Therapeutics shares?

iShares Russell 2000 ETF is the top mutual fund holder of Design Therapeutics shares, with 1.43% of its total shares outstanding invested in 809.27K Design Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools